ZNTL

Latest SEC Filings & News for ZNTL

2 most recent filings and news items mentioning ZNTL. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/ZNTL/news?limit=20"

Pull ZNTL filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
Trading IdeasJul 17, 2026Neutral

ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday

ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday

View filing at SEC.gov →
RegulatoryMay 21, 2026Positive

Zentalis announces Phase 1b MUIR trial data for azenosertib plus paclitaxel in ovarian cancer

Zentalis Pharmaceuticals presented Phase 1b MUIR trial results showing 39% overall response rate and 7.3-month median PFS for azenosertib combined with paclitaxel in platinum-resistant ovarian cancer patients. The data demonstrates a manageable safety profile and supports continu

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.